A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.
Chao LiuLi LiKehan SongZhi-Ying ZhanYi YaoHongyun GongYuan ChenQun WangXiaorong DongZhibin XieChun-Quan OuQinyong HuQibin SongPublished in: Journal for immunotherapy of cancer (2020)
Increasing age, receipt of antitumor treatment within 3 months before COVID-19 diagnosis, elevated WBC count and dNLR, and having dyspnea on admission were independent risk factors for mortality among patients with COVID-19 and solid tumors. The nomogram based on these factors accurately predicted mortality risk for individual patients.